1. Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study. (15th January 2020) Authors: Yang, H.; Bouma, B.J.; Dimopoulos, K.; Khairy, P.; Ladouceur, M.; Niwa, K.; Greutmann, M.; Schwerzmann, M.; Egbe, A.; Scognamiglio, G.; Budts, W.; Veldtman, G.; Opotowsky, A.R.; Broberg, C.S.; Gumbiene, L.; Meijboom, F.J.; Rutz, T.; Post, M.C.; Moe, T.; Lipczyńska, M. Journal: International journal of cardiology Issue: Volume 299(2020) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗